Refractory Shock Secondary to Denosumab-induced Severe Hypocalcaemia
{{output}}
Denosumab is one of the most commonly used antiresorptive drugs for osteoporosis treatment and the prevention of skeletal-related events in cancer patients. The purpose of this case report is to highlight potentially life-threatening severe hypocalcaemia as a ... ...